Advances in psychiatry and nuerology


ISSN 1234-8279

ISSN on-line 2449-9315 

 

As of July 2026, the journal's publisher is Wroclaw Medical University: https://ppn.umw.edu.pl/en/about/.

 

CiteScore 2025: 0.4

MNiSW: 20

Index Copernicus 2023: 90.54

Editorial panel
Submitting and reviewing works online

Archive 1995–2023

2002, volume 18, issue 2
Article

Leczenie choroby Wilsona

Farmakoterapia w Psychiatrii i Neurologii, 2002, 2, 148-152
Summary

In the present study current therapeutic possibilities were described. Wilson’s disease is a genetic disorder of cooper metabolism. Since the fifties of the past century it led inevitable to death, but after the introduction of chelating therapy the prognosis is good. Nowadays in Poland there are two specimens available in treatment of this disease: d-penicillamine and zinc sulphate, both are equally effective, but d-penicillamine has more side effects. The prognosis of survival in the majority of WD patients is favorable, provided that therapy is introduced in not very advanced stage of disease and long live continued.

You have added an item to your cart
Restore password
Shopping cart (0)
No products in your cart
Font size
Contrast
Underlined links